查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1573009

血液 DNA套件市场：按技术、最终用户划分 - 2025-2030 年全球预测

Blood DNA Kit Market by Technology (Next-Generation Sequencing, Polymerase Chain Reaction), End User (Hospital and Clinics, Research Centers) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

血液 DNA套件市场价值 2023 年为 8.6736 亿美元，预计到 2024 年将达到 9.3638 亿美元，复合年增长率为 6.48%，到 2030 年将达到 13.4673 亿美元。

血液 DNA套件市场的范围和定义包括为基因检测、法医学和健康诊断而设计的各种产品。这些套件有助于从血液样本中提取和分析 DNA，并在精准医疗、谱系测试和个人化治疗策略中发挥重要作用。随着基因组学和生物技术的进步，对个人化医疗和疾病早期检测的需求不断增长，从而推动了对血液 DNA套件的需求。这些套件对于多种应用至关重要，包括遗传疾病诊断、药物基因组学和肿瘤学研究。最终使用领域包括医疗机构、法医学实验室、研究机构等。市场成长受到遗传疾病诊断意识增强、政府对基因组计划的支持以及提高 DNA 分析准确性和速度的技术进步等因素的影响。在医疗保健基础设施不断发展的新兴市场中，成长机会显而易见。公司可以透过扩大分销网络和开发适合当地需求的经济高效的套件来利用这些机会。然而，扩大市场也带来了挑战，包括先进套件的高成本、围绕基因资料隐私的道德问题以及可能延迟产品核可的严格法规结构。产业公司必须专注于非侵入式测试方法和自动化的创新，以降低成本并改善使用者体验。持续的研发投入可以带来多标靶检测套组的突破，进而拓宽应用范围。市场竞争激烈，併购是取得竞争优势的常见策略。因此，企业应探索与医疗保健提供者和研究机构的策略联盟和研究合作，以优化销售管道并增加其市场占有率。透过主动解决资料隐私问题并适应监管标准，公司可以有效应对市场挑战。

主要市场统计
基准年[2023] 8.6736 亿美元
预测年份 [2024] 93638万美元
预测年份 [2030] 13.4673 亿美元
复合年增长率（%） 6.48%

市场动态：揭示快速发展的血液 DNA套件市场的关键市场洞察

供需的动态交互作用正在改变血液 DNA套件市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 临床实验室越来越多地采用血液 DNA套件进行诊断
    • 透过基因组学和相关技术的进步提高血液 DNA套件的准确性
    • 需要早期诊断的遗传疾病和慢性病盛行率上升
    • 对个人化医疗的需求不断增长，推动了对高效 DNA检测套组的需求
  • 市场限制因素
    • 对高度专业化设备和熟练人员的需求增加了血液 DNA套件製造商的营运成本
  • 市场机会
    • 遗传疾病和癌症盛行率的上升促使人们采用血液 DNA检测套组。
    • 预防保健意识的增强促使消费者使用血液 DNA套件
    • 由于血液 DNA 检测在祖先和系谱研究中的广泛使用，市场需求增加
  • 市场挑战
    • 样本品质和采集方法的变化可能导致测试结果不一致且不可靠，进而影响市场成长。

波特五力：驾驭血液 DNA套件市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解血液 DNA套件市场的外部影响

外部宏观环境因素在塑造血液 DNA套件市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解血液 DNA套件市场的竞争状况

血液 DNA套件市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵血液 DNA套件市场供应商的绩效评估

FPNV 定位矩阵是评估血液 DNA套件市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

制定血液 DNA套件市场成功之路的策略分析与建议

血液 DNA套件市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 临床实验室越来越多地采用血液 DNA套件进行诊断
      • 基因组学和相关技术的进步提高了血液 DNA套件的准确性
      • 需要早期诊断的遗传疾病和慢性病增加
      • 对个人化医疗的需求不断增长，增加了对高效 DNA检测套组的需求
    • 抑制因素
      • 对高度专业化的设备和熟练人员的需求增加了血液 DNA套件製造商的营运成本。
    • 机会
      • 遗传疾病和癌症发生率的上升推动了血液 DNA套件的推出
      • 预防保健意识的提高促使消费者使用血液 DNA套件
      • 血液DNA检测在血统和家谱研究的应用扩大，市场需求增加
    • 任务
      • 样本品质和采集方法的变化可能导致测试结果不一致且不可靠，进而影响市场成长。
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章血液 DNA套件市场：依技术分类

  • 次世代定序
  • 聚合酵素链锁反应

第七章 血液 DNA套件市场：依最终用户分类

  • 医院和诊所
  • 研究中心

第八章北美及南美血液DNA套件市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太血液DNA套件市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲血液DNA套件市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-2B5802CFEA27

The Blood DNA Kit Market was valued at USD 867.36 million in 2023, expected to reach USD 936.38 million in 2024, and is projected to grow at a CAGR of 6.48%, to USD 1,346.73 million by 2030.

The scope and definition of the Blood DNA Kit market encompass a range of products designed for genetic testing, forensics, and health diagnostics. These kits facilitate the extraction and analysis of DNA from blood samples, playing a critical role in precision medicine, ancestry testing, and personalized treatment strategies. The necessity for blood DNA kits is driven by the increasing demand for personalized medicine and early disease detection, heightened by advancements in genomics and biotechnology. These kits are crucial in various applications such as genetic disorder diagnosis, pharmacogenomics, and oncology research. End-use sectors include healthcare institutions, forensic laboratories, and research organizations. Market growth is influenced by factors such as rising awareness about genetic disease diagnosis, government support for genomic projects, and advancements in technology that enhance accuracy and speed of DNA analysis. Opportunities for growth are evident in emerging markets where healthcare infrastructure is evolving. Companies can capitalize on these opportunities by expanding distribution networks and developing cost-effective kits tailored to local needs. However, market expansion faces challenges such as high costs of advanced kits, ethical concerns surrounding genetic data privacy, and stringent regulatory frameworks that may delay product approvals. Industry players need to focus on innovations in non-invasive testing methods and automation to reduce costs and enhance user experience. Continued investment in research and development can lead to breakthroughs in multi-target testing kits, thereby broadening application scope. The nature of the market is highly competitive, with mergers and acquisitions being common strategies for gaining a competitive edge. Therefore, companies should explore strategic partnerships and collaborations with healthcare providers and research institutions to optimize distribution channels and strengthen market presence. By proactively addressing data privacy concerns and adapting to regulatory standards, businesses can effectively navigate market challenges.

KEY MARKET STATISTICS
Base Year [2023] USD 867.36 million
Estimated Year [2024] USD 936.38 million
Forecast Year [2030] USD 1,346.73 million
CAGR (%) 6.48%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood DNA Kit Market

The Blood DNA Kit Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increased adoption of blood DNA kits by clinical laboratories for diagnostic purposes
    • Advancements in genomics and related technologies enhancing blood DNA kit accuracy
    • Rising prevalence of genetic disorders and chronic diseases necessitating early diagnosis
    • Growing demand for personalized medicine driving the need for efficient DNA testing kits
  • Market Restraints
    • The need for highly specialized equipment and skilled personnel increases operational expenses for blood DNA kit manufacturers
  • Market Opportunities
    • Rising prevalence of genetic disorders and cancers spurring the adoption of blood DNA kits
    • Growing awareness about preventive healthcare encouraging consumers to use blood DNA kits
    • Expanding applications of blood DNA testing in ancestry and genealogy research increasing market demand
  • Market Challenges
    • Variability in sample quality and collection methods can lead to inconsistent and unreliable test results, impacting market growth

Porter's Five Forces: A Strategic Tool for Navigating the Blood DNA Kit Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood DNA Kit Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood DNA Kit Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood DNA Kit Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood DNA Kit Market

A detailed market share analysis in the Blood DNA Kit Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood DNA Kit Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood DNA Kit Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood DNA Kit Market

A strategic analysis of the Blood DNA Kit Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood DNA Kit Market, highlighting leading vendors and their innovative profiles. These include 23andMe Inc., Ancestry.com LLC, Color Genomics Inc., Dante Labs, DNAfit, EasyDNA, Embark Veterinary Inc., FamilyTreeDNA, Futura Genetics, GenoPalate Inc., Genos Inc., Helix OpCo LLC, Living DNA Ltd., Mapmygenome India Ltd., MyHeritage Ltd., Nebula Genomics, Orig3n Inc., Pathway Genomics Corporation, Veritas Genetics Inc., and Xcode Life Sciences.

Market Segmentation & Coverage

This research report categorizes the Blood DNA Kit Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Next-Generation Sequencing and Polymerase Chain Reaction.
  • Based on End User, market is studied across Hospital and Clinics and Research Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased adoption of blood DNA kits by clinical laboratories for diagnostic purposes
      • 5.1.1.2. Advancements in genomics and related technologies enhancing blood DNA kit accuracy
      • 5.1.1.3. Rising prevalence of genetic disorders and chronic diseases necessitating early diagnosis
      • 5.1.1.4. Growing demand for personalized medicine driving the need for efficient DNA testing kits
    • 5.1.2. Restraints
      • 5.1.2.1. The need for highly specialized equipment and skilled personnel increases operational expenses for blood DNA kit manufacturers
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising prevalence of genetic disorders and cancers spurring the adoption of blood DNA kits
      • 5.1.3.2. Growing awareness about preventive healthcare encouraging consumers to use blood DNA kits
      • 5.1.3.3. Expanding applications of blood DNA testing in ancestry and genealogy research increasing market demand
    • 5.1.4. Challenges
      • 5.1.4.1. Variability in sample quality and collection methods can lead to inconsistent and unreliable test results, impacting market growth
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Blood DNA Kit Market, by Technology

  • 6.1. Introduction
  • 6.2. Next-Generation Sequencing
  • 6.3. Polymerase Chain Reaction

7. Blood DNA Kit Market, by End User

  • 7.1. Introduction
  • 7.2. Hospital and Clinics
  • 7.3. Research Centers

8. Americas Blood DNA Kit Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Blood DNA Kit Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Blood DNA Kit Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 23andMe Inc.
  • 2. Ancestry.com LLC
  • 3. Color Genomics Inc.
  • 4. Dante Labs
  • 5. DNAfit
  • 6. EasyDNA
  • 7. Embark Veterinary Inc.
  • 8. FamilyTreeDNA
  • 9. Futura Genetics
  • 10. GenoPalate Inc.
  • 11. Genos Inc.
  • 12. Helix OpCo LLC
  • 13. Living DNA Ltd.
  • 14. Mapmygenome India Ltd.
  • 15. MyHeritage Ltd.
  • 16. Nebula Genomics
  • 17. Orig3n Inc.
  • 18. Pathway Genomics Corporation
  • 19. Veritas Genetics Inc.
  • 20. Xcode Life Sciences

LIST OF FIGURES

  • FIGURE 1. BLOOD DNA KIT MARKET RESEARCH PROCESS
  • FIGURE 2. BLOOD DNA KIT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BLOOD DNA KIT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD DNA KIT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD DNA KIT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BLOOD DNA KIT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BLOOD DNA KIT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BLOOD DNA KIT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BLOOD DNA KIT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BLOOD DNA KIT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD DNA KIT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BLOOD DNA KIT MARKET DYNAMICS
  • TABLE 7. GLOBAL BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD DNA KIT MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD DNA KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD DNA KIT MARKET SIZE, BY HOSPITAL AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD DNA KIT MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. BLOOD DNA KIT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 100. BLOOD DNA KIT MARKET, FPNV POSITIONING MATRIX, 2023